A troubling new study published in Addictive Behaviors has revealed that 7% of pregnant women in the United States are using marijuana, with nearly a third claiming their doctors recommended it. The research, drawing on nationally representative data from 2021–2023, raises serious questions about the growing number of pregnant women using marijuana and the normalisation of cannabis amongst expectant mothers.

The study analysed responses from 1,992 pregnant women aged 18 and older who participated in the National Survey on Drug Use and Health (NSDUH). Researchers found that amongst current users, 31% reported receiving a medical recommendation for marijuana in the past year—a statistic that challenges the fundamental medical principle of “First, do no harm.” The fact that so many pregnant women using marijuana report doctor approval is particularly concerning.

Vulnerable Populations at Greatest Risk

The data revealed disturbing patterns about who is most likely to use cannabis during pregnancy. Women who were younger, unmarried, experiencing serious psychological disturbance, or already using cigarettes and alcohol showed significantly higher rates of prenatal marijuana use.

This concentration amongst vulnerable groups suggests that these expectant mothers using cannabis may be receiving inadequate guidance about the risks. The targeting of at-risk populations with a substance linked to severe health complications for both mother and baby raises ethical concerns about modern medical practices.

Known Health Risks

Medical research has established clear links between pregnant women using marijuana and serious health problems. Preeclampsia, a potentially life-threatening condition characterised by high blood pressure, occurs more frequently in women who use cannabis during pregnancy. Additionally, children exposed to marijuana in utero face increased risks of mental health issues that can persist well into childhood.

Despite these documented dangers, the study’s findings suggest that some medical professionals are recommending cannabis to expectant mothers. This concerning trend may stem from the broader cultural shift toward marijuana normalisation, driven partly by commercial interests in the expanding cannabis industry.

The Medical Recommendation Paradox

The revelation that 31% of pregnant women using marijuana report doctor recommendations is particularly alarming. Traditional medical guidance has long advised pregnant women to avoid all unnecessary substances, including alcohol, tobacco, and recreational drugs. The apparent reversal of this cautious approach for cannabis lacks robust scientific support.

Expectant mothers using cannabis deserve evidence-based care that prioritises the wellbeing of both themselves and their unborn children. When medical professionals recommend or tacitly approve marijuana without adequate research demonstrating safety, they potentially expose vulnerable patients to preventable harm.

A Call for Clearer Guidance

The study’s findings highlight an urgent need for consistent, science-based messaging about cannabis use amongst expectant mothers. Healthcare providers must receive updated training on the risks associated with prenatal marijuana exposure and the importance of counselling patients accordingly.

Organisations like Smart Approaches to Marijuana (SAM) have long advocated for evidence-based policies and public health messaging regarding cannabis use. The data from this study underscores the importance of such efforts, particularly when it comes to protecting vulnerable populations like pregnant women using marijuana.

These expectant mothers, particularly those in vulnerable circumstances, require comprehensive support and accurate information to make informed decisions about their health. The current situation, where 7% report marijuana use and nearly a third cite medical recommendations, suggests a significant gap between research evidence and clinical practice.

As the cannabis industry continues to expand and societal attitudes shift, protecting maternal and infant health must remain the paramount concern. Clear communication about the risks facing pregnant women using marijuana can help ensure that expectant mothers receive the accurate guidance they need during this critical period.

Source: thedrugreport